Emergent BioSolutions has confirmed that its over-the-counter (OTC) version of overdose reversal agent Narcan will be available on the shelves of pharmacies, grocery store
Rumours that German pharma Stada may be up for sale have been all but confirmed by the company's chief executive, who told a news agency that "exploratory talks" are takin
Just over a month after getting FDA approval for the first over-the-counter (OTC) topical therapy for erectile dysfunction (ED), Futura Medical has lined up some heavyweig
The first-ever over-the-counter contraceptive pill has finally been approved for sale in the US, extending the choice of birth control options available to women.
Digital health company Akili has launched a non-prescription version of its attention-deficit hyperactivity disorder (ADHD) digital therapeutic EndeavorRx, that can be dow
Two-year data with eyeDNA Therapeutics’ gene therapy for retinitis pigmentosa (RP), an inherited form of blindness, has prompted the biotech to seek discussions with regul
It’s 2024, and in most clinical trials, data is still being moved from the EHR to the EDC manually – with employees reading data from one screen and typing it onto another.